China's consumer, factory prices skid as demand falters

China's consumer inflation hit an 18-month low and factory-gate price declines sped up in March as demand stayed persistently weak, shoring up the case for policymakers to take more steps to support the uneven economic recovery.

newspaper

11-04-2023

China's consumer inflation hits 18-month low amid uneven recovery

BEIJING (Reuters) -China's consumer inflation in March hit the slowest pace since September 2021, weighed by sluggish food prices, official data showed on Tuesday, suggesting demand weakness persists amid an uneven economic recovery.

newspaper

11-04-2023

China's March consumer inflation lowest since Sept 2021

China's consumer inflation in March hit the slowest pace since September 2021, driven by falling food prices, official data showed on Tuesday, suggesting demand weakness persists amid an uneven economic recovery.

newspaper

11-04-2023

Indonesia to propose limited free trade deal with US on critical minerals

Indonesia will propose a free trade agreement for some minerals shipped to the United States so that companies in the electric vehicle battery supply chain operating in the country can benefit from U.S. tax credits, a senior minister said on Monday.

newspaper

10-04-2023

China tax department says economy's rebound to be further consolidated

The rebound of China's economy will be further consolidated and tax revenues in the second quarter will likely grow faster, but the economy still faces many uncertainties at home and abroad, the taxation administration said on Thursday.

newspaper

06-04-2023

China March services activity accelerates on new orders - Caixin PMI

China's services activity in March revved up at the quickest pace in 2-1/2 years on robust new orders and job creation and a consumption-led post-COVID recovery, a private-sector survey showed on Thursday.

newspaper

06-04-2023

Drugmaker AbbVie trims profit forecasts on IPR&D expenses

(Reuters) -AbbVie Inc on Wednesday lowered its full-year and first-quarter profit expectations, citing a $150 million hit from acquired in-process research and development (IPR&D) and milestone expenses.

newspaper

05-04-2023

AbbVie signals Q1 hit from R&D expenses

AbbVie Inc said on Wednesday it expects first-quarter earnings to be hit by acquired in-process research and development (IPR&D) and milestones expenses.

newspaper

05-04-2023